NASDAQ:TRHC

Tabula Rasa HealthCare Stock Forecast, Price & News

$43.31
-0.34 (-0.78 %)
(As of 04/23/2021 12:27 PM ET)
Add
Compare
Today's Range
$42.79
Now: $43.31
$43.83
50-Day Range
$34.50
MA: $43.26
$48.04
52-Week Range
$30.12
Now: $43.31
$69.31
Volume2,256 shs
Average Volume420,281 shs
Market Capitalization$1.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.05
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates through two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise software that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing programs or systems. The company also provides RxCompanion, a cloud-based MTM software platform designed to aid in the identification and resolution of medication and other health related problems; TruChart, a web-based electronic health record for Programs of All-Inclusive Care for the Elderly (PACE) organizations; PACElogic, which delivers real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state required reporting. In addition, the company offers DoseMeRx, a decision support software; PrescribeWellness, a patient engagement center platform; and clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2020, it served approximately 130 healthcare organizations; and 280 health plans and approximately 14,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Tabula Rasa HealthCare logo

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767
Employees1,614
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$284.71 million
Cash Flow$1.50 per share
Book Value$8.36 per share

Profitability

Net Income$-32,440,000.00

Miscellaneous

Market Cap$1.07 billion
Next Earnings Date5/6/2021 (Confirmed)
OptionableOptionable

Headlines

Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Price Down 5%
April 6, 2021 |  americanbankingnews.com
Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2020 Results
February 23, 2021 |  markets.businessinsider.com
See More Headlines

MarketRank

Overall MarketRank

1.26 out of 5 stars

Medical Sector

870th out of 2,025 stocks

Business Services, Not Elsewhere Classified Industry

76th out of 192 stocks

Analyst Opinion: 3.2Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$43.31
-0.34 (-0.78 %)
(As of 04/23/2021 12:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

Is Tabula Rasa HealthCare a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Tabula Rasa HealthCare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View analyst ratings for Tabula Rasa HealthCare
or view top-rated stocks.

What stocks does MarketBeat like better than Tabula Rasa HealthCare?

Wall Street analysts have given Tabula Rasa HealthCare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tabula Rasa HealthCare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Tabula Rasa HealthCare?

Tabula Rasa HealthCare saw a decline in short interest in March. As of March 15th, there was short interest totaling 3,580,000 shares, a decline of 28.0% from the February 28th total of 4,970,000 shares. Based on an average daily volume of 480,600 shares, the days-to-cover ratio is currently 7.4 days.
View Tabula Rasa HealthCare's Short Interest
.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Tabula Rasa HealthCare
.

How can I listen to Tabula Rasa HealthCare's earnings call?

Tabula Rasa HealthCare will be holding an earnings conference call on Thursday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) released its quarterly earnings results on Wednesday, February, 24th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.02. The business earned $77.05 million during the quarter, compared to the consensus estimate of $75.80 million. Tabula Rasa HealthCare had a negative net margin of 19.48% and a negative trailing twelve-month return on equity of 11.53%.
View Tabula Rasa HealthCare's earnings history
.

How has Tabula Rasa HealthCare's stock price been impacted by COVID-19 (Coronavirus)?

Tabula Rasa HealthCare's stock was trading at $45.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRHC stock has decreased by 6.0% and is now trading at $43.11.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TRHC?

9 brokers have issued 12 month price targets for Tabula Rasa HealthCare's shares. Their forecasts range from $40.00 to $72.00. On average, they expect Tabula Rasa HealthCare's stock price to reach $52.20 in the next year. This suggests a possible upside of 21.1% from the stock's current price.
View analysts' price targets for Tabula Rasa HealthCare
or view top-rated stocks among Wall Street analysts.

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the following people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 71, Pay $616.28k)
  • Dr. Orsula Voltis Knowlton M.B.A., Pharm.D., BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 52, Pay $470.08k)
  • Mr. Brian W. Adams, CFO & Sec. (Age 39, Pay $647.74k)
  • Mr. Michael Greenhalgh, Chief Operating Officer (Age 59)
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 39)
  • Mr. Bob Sullivan M.S., Chief Technology Officer
  • Mr. Joseph J. Filippoli, Chief Information Officer (Age 55)
  • Dr. Jacques Turgeon, Chief Scientific Officer (Age 61)
  • Mr. Phillip W. Heath MS, Chief Admin. Officer (Age 55)
  • Mr. Frank Sparacino C.F.A., CPA, CFA, CPA, Sr. VP of Investor Relations & Corp. Devel.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare CEO Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among Tabula Rasa HealthCare's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), (CGC), The Boeing (BA), salesforce.com (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Compagnie Lombard Odier SCmA (1.40%), Summit Creek Advisors LLC (0.77%), Taylor Wealth Management Partners (0.50%), Exchange Traded Concepts LLC (0.33%), New York State Teachers Retirement System (0.10%) and State of Alaska Department of Revenue (0.06%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton and Samira Beckwith.
View institutional ownership trends for Tabula Rasa HealthCare
.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Summit Creek Advisors LLC, and New York State Teachers Retirement System. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton, and Samira Beckwith.
View insider buying and selling activity for Tabula Rasa HealthCare
or view top insider-selling stocks.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including Compagnie Lombard Odier SCmA, Exchange Traded Concepts LLC, Taylor Wealth Management Partners, Everence Capital Management Inc., Oregon Public Employees Retirement Fund, and Crossmark Global Holdings Inc..
View insider buying and selling activity for Tabula Rasa HealthCare
or or view top insider-buying stocks.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $43.11.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare has a market capitalization of $1.06 billion and generates $284.71 million in revenue each year. The company earns $-32,440,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

Tabula Rasa HealthCare employs 1,614 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com.

Where are Tabula Rasa HealthCare's headquarters?

Tabula Rasa HealthCare is headquartered at 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.